Distribution of Johnson's anti-corona vaccine in the United States

The United States began shipping a single-dose coronavirus vaccine from Johnson & Johnson, marking the third stage in the nation's vaccination arsenal after the green light the vaccine received for emergency use from the FDA and the Centers for Disease Control and Prevention (CDC), according to When it was published on Fox News America.

McKesson, the distribution partner chosen by the US government to manage vaccine distribution, announced that it has begun distributing the new vaccine, and the McKesson Claremont facility in Shepherd'sville, Kentucky, has seen vials packed into insulated coolers and loaded onto UPS trucks, and McKesson indicated that there are four distribution centers involved. In the launch of the corona virus vaccine Johnson & Johnson in the United States.

On the other hand, Alex Gorsky, CEO of Johnson & Johnson, told the "Today" program on NBC that the doses could start within the next two days.

 The president of "Johnson & Johnson" added that he believed in the next 24 to 48 hours that Americans should start getting the shots in their arms, as they flock to the trucks during our conversation.

Johnson & Johnson president previously explained that nearly 4 million doses will be shipped this week, with 20 million doses available by the end of March, although the supply is expected to be erratic this month, the company expects 60 million shots to be delivered by spring and 100 One million vaccines total to the United States by mid-2021, and Dr. Rochelle Walinsky, director of the CDC, issued a statement after a vaccine advisory panel recommended the vaccine for adults ages 18 and over.

The difference between the Johnson & Johnson vaccine and the Pfizer and Moderna vaccines?

While both Pfizer and Moderna require a two-dose regimen, the Johnson vaccine requires only one dose. Late clinical trials also showed that the Pfizer vaccine was 95% effective against acute coronavirus disease, while the efficacy of Moderna was 94.1%, and a Johnson candidate had an efficacy of 66.9%. However, the "efficacy" under controlled conditions in clinical trials is not It is the same as "agency" in imperfect real-world conditions. Results this week showed that the Pfizer vaccine was 94% effective in a global study of nearly 1.2 million people, consistent with the high efficacy reported during clinical trials.